Réduction des maladies cardiovasculaires et dépenses de santé au Québec à l’horizon 2050*

Short summary: 

Cardiovascular diseases (CVD), including hypertension and strokes, account for an important share of mortality and direct health costs in Quebec. In this study, we use a microsimulation model to project public expenditure on hospitalizations and physician consultations to 2050, under various scenarios of the evolution of CVD. A plausible scenario, of an immediate 30% decrease in CVD incidence due to better prevention, yields cumulative savings of $21 billion in present value, to which another $66 billion (in 2012 $) can be added for the economic value of the life-years saved over the period.

Publication Authors: 
David Boisclair
Yann Décarie
François Laliberté-Auger
Pierre-Carl Michaud
Number: 
16-01
Year: 
Scientific article : 

Partners

Industrielle Alliance, Groupe financier

2019 © Chaire de recherche Industrielle Alliance sur les enjeux économiques des changements démographiques